Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Selective inhibition of the mitochondrial permeability transition pore protects against neuro-degeneration in experimental multiple sclerosis.
Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab.
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion.
Application of fullerenes in nanomedicine: an update.
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Receptos announces issuance of composition of matter patents covering proprietary lead product candidate RPC1063
Clinical profile of malay children with optic neuritis.
Glatiramer acetate treatment negatively regulates type I interferon signaling.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
A meta-analysis of whole genome linkage screens in multiple sclerosis.
The effects of long-term interferon- beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
Differential roles of microglia and monocytes in the inflamed central nervous system.
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Title: Pharmacokinetics and Pharmacodynamics of Peginterferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in the Randomised ADVANCE Study.
Specific peripheral B cell tolerance defects in patients with multiple sclerosis.
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).
The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.

Pages